All Pathways
NeurologyEmergency

Refractory Status Epilepticus Management

Refractory Status Epilepticus Management: Refractory Status Epilepticus → Confirm Refractory SE (RSE) → Immediate Actions → Select Continuous IV Anesthe...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Refractory Status Epilepticus

    SE persisting after benzodiazepine + first-line AED

    1. Action

      Confirm Refractory SE (RSE)

      Definition and criteria

      • Seizures persist after adequate benzo dose
      • AND after one first-line AED (fosphenytoin, VPA, LEV)
      • Typically 20-30 min from onset
      • Start continuous EEG monitoring
      1. Action

        Immediate Actions

        Secure airway and prepare for anesthesia

        • Intubate for airway protection
        • Arterial line for BP monitoring
        • Central venous access
        • Continuous EEG (cEEG) initiation
        • Vasopressor support ready
        1. Decision

          Select Continuous IV Anesthetic (CIVA)

          Choose based on patient factors

          • Midazolam - less hypotension
          • Propofol - fast on/off, PRIS risk
          • Pentobarbital - most potent, most side effects
          • Ketamine - emerging evidence
          1. Action

            Midazolam Infusion

            Often first-line for RSE

            • Load: 0.2 mg/kg bolus
            • Infusion: 0.1-2 mg/kg/hr
            • Titrate to EEG target
            • Repeat boluses 0.2 mg/kg PRN
            • Less hypotension than others
            1. Decision

              EEG Suppression Target

              What level of suppression?

              • Seizure suppression (minimum)
              • Burst suppression (moderate)
              • Isoelectric (maximum)
              • No clear evidence one is superior
              1. Action

                Burst Suppression Target

                Most common target

                • 1-10 bursts per minute
                • Maintain for 24-48 hours initially
                • Slow wean attempt after stable
                • Continue maintenance AEDs
                1. Action

                  Wean Attempt

                  After 24-48h of seizure control

                  • Reduce CIVA by 25-50% q6-12h
                  • Continuous EEG during wean
                  • Ensure AED levels therapeutic
                  • Watch for breakthrough seizures
                  1. Decision

                    Seizure Recurrence?

                    Breakthrough during wean

                    1. Outcome

                      Successful Wean

                      Seizure freedom off anesthetics

                      • Continue maintenance AEDs
                      • Prolonged EEG monitoring (24-48h)
                      • ICU observation
                      • Investigate etiology
                    2. Warning

                      ⚠️ Super-Refractory SE (SRSE)

                      SE continues/recurs ≥24h after anesthesia

                      • Occurs in ~10-15% of RSE
                      • Consider ketamine addition
                      • Immunotherapy if suspected autoimmune
                      • Hypothermia, ketogenic diet
                      • Neurosurgery if focal lesion
                      • Very high mortality (30-50%)
                      1. Action

                        Consider Ketamine

                        NMDA antagonist for RSE/SRSE

                        • Load: 1-3 mg/kg
                        • Infusion: 1-10 mg/kg/hr
                        • May add to midazolam/propofol
                        • Fewer hemodynamic effects
                        • Growing evidence base
                        1. Warning

                          Goals of Care Discussion

                          If SRSE persists despite all measures

                          • Mortality 30-50% in SRSE
                          • Survivors often have morbidity
                          • Involve family, palliative care
                          • Consider comfort measures
              2. Action

                Seizure Suppression Only

                Less aggressive approach

                • Titrate to abolish electrographic seizures
                • Background may show slowing
                • Less hemodynamic compromise
                • Consider if stable
          2. Action

            Propofol Infusion

            Rapid onset, lipid soluble

            • Load: 1-2 mg/kg bolus
            • Infusion: 1-15 mg/kg/hr
            • Monitor for PRIS (propofol infusion syndrome)
            • Check triglycerides, CK, lactate
            • Limit to <5 mg/kg/hr if >48h
          3. Action

            Pentobarbital Infusion

            Most potent, last resort

            • Load: 5-15 mg/kg
            • Infusion: 0.5-5 mg/kg/hr
            • Target: burst suppression on EEG
            • Significant hypotension expected
            • Prolonged recovery (days)

Guideline Source

Guidelines for the Evaluation and Management of Status Epilepticus - Neurocritical Care Society

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Pediatric dosing differs significantly
  • Requires ICU-level monitoring with continuous EEG
  • Drug choice may vary by institutional protocol
  • Super-refractory SE management less standardized

Applicable Regions

USEUglobal

EU: ILAE recommendations may differ slightly

US: NCS/AES guidelines primarily followed

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Refractory Status Epilepticus Management?

The Refractory Status Epilepticus Management is a emergency clinical algorithm for Neurology. It provides a structured decision tree to guide clinical decision-making, based on Guidelines for the Evaluation and Management of Status Epilepticus - Neurocritical Care Society.

What guideline is the Refractory Status Epilepticus Management based on?

This algorithm is based on Guidelines for the Evaluation and Management of Status Epilepticus - Neurocritical Care Society (DOI: 10.1007/s12028-012-9695-z).

What are the limitations of the Refractory Status Epilepticus Management?

Known limitations include: Pediatric dosing differs significantly; Requires ICU-level monitoring with continuous EEG; Drug choice may vary by institutional protocol; Super-refractory SE management less standardized. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Refractory Status Epilepticus Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free